Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vivos's Pre-Tax Income for the
three
months ended in Dec. 2024 was $-1.02 Mil. Vivos's Revenue for the
three
months ended in Dec. 2024 was $0.01 Mil. Therefore, Vivos's pretax margin for the quarter that ended in Dec. 2024 was -20,460.00%.
The historical rank and industry rank for Vivos's Pretax Margin % or its related term are showing as below:
RDGL'
s Pretax Margin % Range Over the Past 10 Years
Min: -160475 Med: -14475 Max: 25970.83
Current: -10034.48
RDGL's Pretax Margin % is ranked worse than 98.29% of 819
companies
in the Medical Devices & Instruments industry
Industry Median: 0.66
vs RDGL: -10034.48
Vivos Pretax Margin % Historical Data
The historical data trend for Vivos's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Vivos's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivos's Pretax Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vivos's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Vivos's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivos (OTCPK:RDGL) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Vivos Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Vivos's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising highly insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. IsoPet is another product of the company used for the treatment of solid tumors in animals. The company derives revenue through sales of its products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RDGL has been successfully added to your 